Related Experiment Video
Updated: Mar 2, 2026

05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
1.8K
Partial nephrectomy versus radical nephrectomy for clinical localised renal masses
Frank Kunath1,2, Stefanie Schmidt2, Laura-Maria Krabbe2,3
1Department of Urology, University Hospital Erlangen, Krankenhausstrasse 12, Erlangen, Germany, 91054.
The Cochrane Database of Systematic Reviews
|May 10, 2017
Summary
Partial nephrectomy may reduce overall mortality compared to radical nephrectomy for localized kidney cancer. However, evidence quality is low, showing little difference in cancer recurrence or adverse events.
Area of Science:
- Nephrology
- Surgical Oncology
- Urology
Background:
- Partial nephrectomy and radical nephrectomy are surgical options for localized renal cell carcinoma.
- Debate continues regarding the comparative effects of these surgical approaches.
- High-quality studies are needed to inform treatment recommendations.
Purpose of the Study:
- To assess the effects of partial nephrectomy compared with radical nephrectomy for localized renal cell carcinoma.
- To evaluate oncological and safety outcomes of nephrectomy types.
Main Methods:
- A comprehensive literature search was conducted across multiple databases and trial registries.
- One randomized controlled trial comparing partial and radical nephrectomy for small renal masses was included.
- Data extraction and analysis were performed using Review Manager 5.
Main Results:
- The single included trial with 541 participants showed a potential decrease in all-cause mortality with partial nephrectomy (low-quality evidence).
- No significant differences were found in serious adverse events or time-to-recurrence between the two surgical methods (low-quality evidence).
- Limitations included lack of blinding, cross-over, imprecision, and indirectness, precluding subgroup analyses.
Conclusions:
- Partial nephrectomy may be associated with reduced all-cause mortality in localized renal cell carcinoma.
- There appears to be little to no difference in surgery-related mortality, cancer-specific survival, or recurrence rates.
- Further high-quality research is warranted to confirm these findings.

